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Abstract
Introduction—Muscles add sarcomeres in response to stretch, presumably to maintain optimal 
sarcomere length. Clinical evidence from patients with cerebral palsy (CP), who have both 
decreased serial sarcomere number and reduced satellite cells (SCs), suggests a hypothesis that 
SCs may be involved in sarcomere addition.
Methods—A transgenic Pax7-DTA mouse model underwent conditional SC depletion, and their 
soleii were then stretch-immobilized to assess their capacity for sarcomere addition. Muscle 
architecture, morphology, and extra-cellular matrix (ECM) changes were also evaluated.
Results—Mice in the SC-reduced group achieved normal serial sarcomere addition in response 
to stretch. However, muscle fiber cross-sectional area was significantly smaller and was associated 
with hypertrophic extra-cellular matrix (ECM) changes, consistent with fibrosis.
Discussion—While a reduced SC population does not hinder serial sarcomere addition, SCs do 
play a role in muscle adaptation to chronic stretch that involves maintenance of both fiber cross-
sectional area and ECM structure.
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Introduction
Skeletal muscle undergoes remarkable adaptation to extrinsically-imposed length changes in 
order to regulate force-production capacity. The most important example of this 
phenomenon is serial sarcomere addition during longitudinal growth due to external stretch 
imposed by growing bone1. This basic process not only underlies postnatal longitudinal 
muscle growth1 but also occurs in response to many other stretch-inducing stimuli, including 
chronic immobilization2,3, surgical tensioning4, and even distraction osteogenesis5. The 
plasticity of serial sarcomere number allows restoration of force generation in as little as 2 
weeks after perturbation6,7,1–3.
Despite general acceptance of the fact that sarcomerogenesis occurs in adult skeletal muscle, 
the cellular mechanisms that underlie this adaptive process are poorly understood. One 
hypothesis is that satellite cells, i.e. resident skeletal muscle stem cells8, are involved in the 
sarcomere addition response to chronic muscle length change. Satellite cells (SCs) have 
been shown to be indispensible mediators of muscle growth during periods of postnatal 
development and regeneration following injury9–12. Specifically, they serve as the source of 
new myonuclei and myoblasts during muscle growth and repair13–16.
While no studies to date have directly evaluated the role that SCs play in the muscle 
response to chronic stretch, there are observations from the cerebral palsy (CP) literature that 
suggest that they may be involved in the process of serial sarcomere addition. Spastic CP is 
characterized by impaired longitudinal muscle growth, persistent resistance to muscle 
stretch, and associated contracture formation17. CP patients have significantly longer 
sarcomere lengths18–20, reduced serial sarcomere number19, reduced myofiber area20, and 
weakness21 compared to their typically-developing counterparts, which suggests impairment 
in the ability to add serial sarcomeres. A pertinent point is that children with CP have a 
decreased number of SCs within contractured muscles, approximately 40% of expected22,23. 
These 2 findings, decreased SC number and altered sarcomere number, lead to the 
provocative suggestion that SCs may be responsible for mediating sarcomere addition in 
response to muscle length change.
In this study, we test this suggestion directly. To do this, we utilized a transgenic mouse 
model24 that permits conditional SC ablation. We hypothesized that, after SC depletion, 
chronically-stretched muscles would be unable to add sarcomeres in series, leading to 
pathological muscle changes.
Materials and methods
Animal Subjects
Experiments were performed on 2 groups of mixed-gender young adult mice: wild-type 
C57BL/6 (N=7, aged 8 weeks; The Jackson Laboratory, Bar Harbor, ME, USA) and 
Pax7CreER/+;Rosa26DTA/+, referred to here as Pax7-DTA (N=18, aged 8 weeks)24. They 
were divided into 3 groups: wild-type (WT) control group (N=7, 3 male, negative control), 
Pax7-DTA control group (N=6, 4 male, treatment control), and Pax7-DTA treatment group 
(N=10, 6 male). Pax7CreER/+;Rosa26DTA/+ mice undergo ablation/reduction of their 
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satellite cell number by diphtheria toxin mediated only by treatment with tamoxifen but not 
with a vehicle control24. Mice were housed in a temperature- and humidity-controlled 
environment and maintained on a 12:12 hour light-dark cycle with food and water ad 
libitum. All animal procedures were conducted in accordance with institutional guidelines 
for care and use of laboratory animals as approved by the Animal Care and Use Committee 
of the University of California.
Satellite Cell Ablation
Wild-type control group and Pax7-DTA treatment group were administered tamoxifen (2 
mg/day, dissolved in 10% ethanol in peanut oil; MP Biomedicals, Solon, OH, USA), while 
the Pax7-DTA control group was administered vehicle (10% ethanol in peanut oil) treatment 
via oral gavage for 5 consecutive days. A 10-day washout period was implemented prior to 
casting.
Hindlimb Immobilization
The right hindlimb of each mouse was immobilized in maximal dorsiflexion for 14 days by 
wrapping extra-fast setting plaster strips (BSN medical, Rutherford College, NC, USA) over 
a layer of Webril undercast padding (Covidien, Mansfield, MA USA) secured with a self-
adherent bandage (3M, St. Paul, MN, USA), resulting in plantarflexor stretch and dorsiflexor 
shortening25. The contralateral hindlimb of each animal was not casted and served as an 
internal control. Casts were inspected daily for fraying or loosening and were repaired or 
replaced if their integrity was compromised. Casting and cast repairs were performed with 
mice anesthetized via inhalation of 2% isoflurane (Butler Schein, Dublin, OH, USA) 
delivered by an Ohmeda anesthesia system (model VMA; UK). Most mice were 
anesthetized 1–2 times during the experimental period.
Muscle Harvesting and Fixation
Prior to sacrifice, mice were anesthetized, and the casts were removed to leave the under-
layer of webril and self-adherent bandage in place to maintain the immobilized joint angle. 
A radiograph of the casted hindlimb quantified dorsiflexion angle. Mean ankle joint angle 
was 59.5±3.7° (mean± SEM, N=10) of dorsiflexion from neutral for the experiment group, 
66.3±1.8° (N=7) for the tamoxifen-treated wild-type control, and 68.3±3.6° (N=8) for the 
vehicle-treated Pax7-DTA control (positive values represent dorsiflexion).
Mice were then sacrificed under anesthesia by cervical dislocation. Each hindlimb was 
skinned and transected below the hip. Soleus muscle length was measured in vivo with the 
ankle in neutral. Tibialis anterior (TA), extensor digitorum longus (EDL), and soleus 
muscles were then carefully dissected from the hindlimb, and mass (M) was obtained by 
blotting muscles dry prior to weighing. Muscles were subsequently divided longitudinally to 
provide specimens for fixation or freezing. In addition, gastrocnemius and quadriceps 
muscles were removed to quantify satellite cell number by flow cytometry.
Muscle specimens designated for fixation were pinned at in vivo length (as measured above 
for soleus, estimated for TA/EDL) and fixed for 48 hours in low-odor 10% formalin (Fisher 
Scientific, Fair Lawn, NJ, USA). After fixation, muscles were rinsed 3 times in phosphate-
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buffered saline (PBS) to remove residual fixative and stored in PBS for subsequent analysis. 
Muscle specimens designated for immunohistochemistry were pinned at in vivo length, flash 
frozen in liquid-nitrogen cooled isopentane, and stored at −80° for subsequent analysis.
Flow Cytometry
Quadriceps and gastrocnemius muscles from 8 Pax7-DTA mice (n=4 per treatment group) 
were utilized to quantify SC ablation due to tamoxifen administration. Previously used 
standard procedures for flow cytometry were adapted and utilized 24,22. Briefly, immediately 
after harvest, muscles were placed in 15ml centrifuge tubes containing digestion buffer. 
They were incubated at 37°C and mechanically disrupted with forceps. The cell suspension 
was then filtered with a 40μm mesh. The mixture was centrifuged at 1300 rpm at 4°C for 10 
mins, supernatant was discarded, and the pellet containing the mononuclear cells was 
resuspended in 1 ml fluorescence-activated cell sorting (FACS) buffer [1 mM 
Ethylenediaminetetraacetic acid (EDTA), 2.5% goat serum in phosphate-buffered saline 
(PBS), pH 7.4]. Fluorophore conjugated antibodies for specific markers for SCs, endothelial 
cells, and inflammatory cells were used for each of the samples: α7-integrin (Ablab, 1:200), 
CD31 (eBiosciences, 1:200), CD45 (eBiosciences, 1:200), respectively. An unconjugated 
antibody for NCAM (BD Biosciences, 1:200) was used along with a secondary fluorescent 
antibody (Goat anti-mouse Alexafluor 488, Invitrogen). Unstained controls and gating 
[Fluorescence minus one (FMO)] controls were used to ensure appropriateness of labeling.
Flow cytometry was performed using a FACS Canto (BD Biosciences, San Jose, CA, USA) 
instrument. PE fluorochromes were used for α7-integrin and NCAM, Pacific Blue for CD31 
and CD45, and data for 60,000–100,000 cells/sample were obtained. Gating to exclude 
cellular debris and analysis was performed using FlowJo software v10. SCs were identified 
as α7-integrin+/NCAM+/CD31−/CD45− cells. FMO controls (α7-integrin−/NCAM−/CD31+/
CD45+) were used to ensure the specificity of gating for SC.
Muscle Architecture/Serial Sarcomere Number Measurements
Methods for architecture were modified from the protocol previously described in detail26. 
Briefly, fixed specimen muscle length was measured from the origin of the most proximal 
fibers to the insertion of the most distal fibers using digital calipers under a dissecting 
microscope. Muscles were then partially digested in 15% H2SO4 for 30 minutes to facilitate 
fiber dissection.
Multiple fiber bundles (3–6, composed of ~10 fibers each) were then dissected from 
muscles, and a digital caliper was used under the dissecting scope to measure fiber length. 
Fiber length was measured from 3 fiber bundles whenever possible (in a very small number 
of specimens (6 out of 135) there was insufficient tissue available, and only 2 measurements 
were made) and were averaged to provide mean fiber length (Lf) for each sample. Regional 
differences in the muscle have previously been shown to be insignificant25, and were not 
considered.
Physiological cross-sectional area (PCSA) was calculated using the standard equation27:
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(1)
Literature values for pennation angles (θ) of the TA, EDL, and soleus26, and muscle density 
(ρ, g/mm3)28 were used, and values for mass (M; g) and fiber length (Lf; mm) were 
measured directly. Muscle fiber lengths were normalized to a resting sarcomere length of 2.5 
μm to permit comparisons among groups29.
Serial sarcomere number (SN) was determined using the standard equation:
(2)
Sarcomere length measurement (Ls) was initially attempted using the classic laser diffraction 
method30. However, due to the significant amount of derangement encountered in 
tamoxifen-treated Pax7-DTA mice, clear laser diffraction patterns could not be obtained. 
Sarcomere lengths were therefore measured optically using bright-field microscopy at 40X 
magnification (Leica DM3000, Buffalo Grove, IL, USA). The distance between 10–15 serial 
Z-bands representative of each sample was measured using the computerized caliper and 
dividing by the corresponding number of sarcomeres to determine mean sarcomere length 
for each bundle. Measurements were made on 3–5 bundles and were averaged to provide a 
mean sarcomere length for the muscle. Sarcomere number was then calculated by dividing 
the mean fiber length by the mean sarcomere length (Equation 2).
Muscle Histology and Immunohistochemistry
Serial cross-sections (10μm) of flash-frozen soleus muscles embedded in optimal cutting 
temperature (OCT) compound were created on a cryostat at −25°C (Microm HM500, 
Walldorf, Germany). Slides were stored at −20°C until the histology or 
immunohistochemistry protocols. Standardized protocols for hematoxylin and eosin (H&E) 
staining were used to evaluate general muscle morphology. For immunohistochemistry, 
slides were washed with PBS, then covered with a blocking solution (2% BSA, 5% FBS, 
0.2% Triton X-100, 2% goat serum, 1xPBS) for 30 minutes. A primary antibody (Laminin 
9393, rabbit polyclonal, Sigma, St. Louis, MI, USA) and a secondary antibody for laminin 
(Alexafluor 488 goat anti-rabbit IgG, Invitrogen) were utilized. A fluorescent mounting 
medium containing 4′, 6-diamidino-2-phenylindole (DAPI) to stain for nuclei was used, and 
slides were sealed with a cover slip. Muscle fiber area was calculated from laminin labeled 
sections for at least 150 myofibers per sample using ImageJ (NIH, Bethesda, MD, USA) as 
described previously31.
The fraction of the cross-section occupied by muscle fibers (i.e., muscle area fraction) was 
calculated from soleus H&E stained sections using ImageJ (NIH, Bethesda, MD, USA). 
Images of 3–4 sections per specimen were obtained under 10X objective. Color thresholding 
based on hue and saturation of the H&E stained sections was used to differentiate the muscle 
region, stained pink, from the non-muscle region, such as extracellular matrix, stained white. 
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Muscle area measurements were then normalized to the area of the whole tissue section 
(100%), which we refer to as muscle area fraction.
Statistical Analysis
SCs were expressed as percentage of mononuclear cells for both tamoxifen and vehicle 
groups. Samples in the tamoxifen group were normalized to the average value of the vehicle 
group as the measure of SC knockdown. One-way analysis of variance (ANOVA) was used 
to compare percentage of SCs between groups. Significance level (α) for all tests was set to 
0.05. Two-way ANOVA was used to compare mean sarcomere number between 
immobilized and non-immobilized hindlimbs and to compare serial sarcomere numbers 
between the 3 treatment groups along with multiple-comparisons using Sidak post-hoc tests. 
A correlation was performed between SC number, quantified by FACS and sarcomere 
number to evaluate whether the percentage of SCs affected sarcomere addition. PCSA 
differences between limbs were also assessed using the Student t-test (Prism 6.0d; GraphPad 
Software, Inc., La Jolla, CA, USA). A priori power analysis was performed and confirmed 
that 6 animals per group would provide sufficient experimental power to detect a 20% serial 
sarcomere number change. Muscle area fractions were compared between tamoxifen and 
vehicle groups (n=5–6 per group) using a 1-way ANOVA. Average myofiber area was 
compared between the 2 groups using a 1-way ANOVA.
Results
Quantification of SC number was performed at the time of muscle harvest (Fig. 1A), and 
revealed that an average of 0.81± 0.18% of all mononuclear cells in the tamoxifen-treated 
Pax7-DTA group were α7-integrin+/NCAM+/CD31−/CD45− SCs compared to 2.31± 0.39% 
of the vehicle-treated Pax7-DTA cohort (Figs. 1B, 1C). This represented a statistically 
significant 65% SC reduction in the treatment group (P<0.05).
With confirmation of SC knockdown, serial sarcomere number was then calculated for 
treatment and experimental groups. Importantly, and unexpectedly, there was no apparent 
inhibition of serial sarcomere addition in the SC knockdown muscle. Two-way ANOVA 
revealed a main effect for both limb and treatment groups (P<0.01) with no interaction. Post-
hoc multiple comparisons between groups in sides, i.e. casted vs. uncasted, revealed, as 
predicted, that the soleus muscles in the control groups (Fig. 2A, left and right panels) added 
sarcomeres in response to stretch (WT: 3562±347 vs. 2992±415, Vehicle: 3185±440 vs. 
2459±263). However, the SC depleted group (Fig. 2A, center panel) also added sarcomeres 
in a statistically-significant manner (2903±434 vs. 2408±361), indicating that serial 
sarcomerogenesis was not affected by decreased SC number. A difference in serial 
sarcomere number between the Pax7-DTA mice and control C57BL/6 mice was observed on 
a 2-way ANOVA (P<0.01; Fig. 2A black bars). We attributed this result to differences in 
mouse strain. Post-hoc multiple comparisons showed that the differences between the 
treatment groups were only between the WT and the tamoxifen treated groups for both the 
casted and uncasted sides but not between the control groups, i.e., WT and vehicle treated 
mice. No significant correlation was found between serial sarcomere addition and decreased 
SC number (P>0.5, r2=0.03). Shortening-induced sarcomere loss was also unaffected by SC 
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depletion. The tibialis anterior (TA) muscle, an antagonist to the soleus, showed a significant 
decrease in sarcomere number after immobilization-induced shortening, the magnitude of 
which was similar among groups (Fig. 2B, WT: 2951±344 vs. 3396±227, Vehicle: 2707±344 
vs. 3153±200, Tamoxifen: 2689±303 vs. 3265±349).
This finding was further verified by assessing sarcomere length to ensure that mice in each 
group appropriately compensated for chronic stretch. Consistent with previous findings, 
there were no significant side-to-side sarcomere length differences between any of the 
treatment groups for the TA, EDL, or soleus muscles. Tamoxifen-treated Pax7-DTA mice 
were equally adept at maintaining sarcomere length despite the absence of a full cohort of 
SC (Table 1).
Notably, there were significant differences in muscle mass between sides in TA and EDL 
muscles across all treatment groups, consistent with the expected atrophy in the dorsiflexor 
muscle groups. There was no significant difference in soleus muscle mass in any treatment 
cohort (Table 1). However, when evaluating PCSA (which takes into account the effects of 
mass and fiber length) there was a significant side-to-side difference in the soleus muscle 
across all groups. This is consistent with an expected finding of immobilization-induced 
atrophy. Taken together, the results from Table 1 and Figure 2 indicate that SC reduction did 
not inhibit the muscle’s ability to adapt to chronic stretch/shortening by altering serial 
sarcomere number to maintain sarcomere length.
However, despite preservation of serial sarcomere number, SC depleted muscles contained 
important structural alterations in both the muscle fibers and the extracellular matrix. 
Differences in muscle morphology between the vehicle-treated (Fig. 3A, left panel) and 
tamoxifen-treated (Fig. 3A, right panel) Pax7-DTA mice were obvious. A large number (50–
60%) of the stretched muscle fibers in both groups of Pax7-DTA showed centralized nuclei 
indicating that the process of serial sarcomere number addition mimics the regenerative 
process in other muscle models32. Compared to vehicle-treated controls, SC depleted muscle 
displayed mononuclear cell proliferation in the extracellular matrix consistent with fibrosis. 
Soleus muscle area fraction in casted tamoxifen-treated muscle was only 11 ± 6% compared 
to values of 69 ± 3% for casted vehicle-treated muscle and 66 ± 2% for uncasted tamoxifen-
treated muscle (Fig. 3C, P<0.01). Furthermore, myofiber area was significantly decreased in 
SC depleted muscle (Fig. 3D, P<0.05). The tamoxifen-treated Pax7-DTA stretched soleus 
had a fiber area of only 263 ± 48 μm2 compared to 1,396 ± 208 μm2 on the uncasted side 
and 869 ± 263 μm2 in the vehicle treated stretched solei (Fig. 3D). Sarcomere addition can 
be both in series, i.e. along the length of the fiber and in parallel, i.e. within the fiber cross-
section. Fiber area is an indirect measure of sarcomeres in parallel, while serial sarcomere 
number is a measure of sarcomeres in series along the length of the fiber. These data suggest 
that while sarcomere addition observed in series, i.e. serial sarcomere number is permissible 
in the presence of reduced SC number, sarcomere addition in parallel, i.e. fiber size might be 
affected with reduced SC number.
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Discussion
This study demonstrated that stretch-induced sarcomere adaptation is dependent on a full 
cohort of SCs. We used a SC conditional knockdown mouse model, reduced the SC to the 
same level seen in children with CP (30–40%), and induced sarcomerogenesis by stretching 
the soleus muscle in a position of dorsiflexion. While a reduced cohort, such as those seen in 
children with CP, is sufficient for some addition of sarcomeres, a full cohort is needed for 
optimal adaptation, specifically for maintaining myofiber area and regulating the 
extracellular matrix (ECM). Both myofiber area and muscle area fraction were dramatically 
reduced in the cohort with reduced SCs. Furthermore, a large percentage (~50%) of fibers in 
the vehicle group showed clear centralized nuclei, typically indicative of myofiber repair and 
regeneration32. This suggests that the process of sarcomere addition under conditions of 
chronic stretch may be a regenerative process, which requires participation by the SC, but 
this has not been demonstrated before. However this was seen only in a small percentage 
(~10%) of the fibers in the WT mice. Consequently the centralized nuclei might not be as 
indicative of stretch-induced regeneration as much as a Pax7-DTA transgenic mouse-specific 
response. In contrast to a regenerative process such as repair after injury for which SCs are 
indispensable 33 they are dispensable for conditions of hypertrophy 24 and re-growth from 
atrophy 34 with no loss of myonuclei during conditions of atrophy 35. These findings, while 
unexpected based on our initial hypothesis, provide additional evidence that SC depletion 
may be either directly or indirectly (see below) associated with an improper regenerative 
response and inappropriate muscle adaptation.
The role of SCs in regulation of the extracellular matrix has recently been suggested in other 
models that require muscle adaptation to external stimuli. Murphy et al. demonstrated that 
interaction between SCs and fibroblasts are important for appropriate muscle regeneration 
after barium chloride injury36. More recently, Fry et al. showed that activated SCs are 
important regulators of ECM changes in response to muscle overload37. One proposed 
mechanism is that SC activation is associated with upregulation of interstitial collagenases, 
which allow ECM remodeling and SC migration38,39. These studies indicate that a major 
role of the SC may be to “manage” the response of the extracellular matrix to external 
stimuli, a finding strongly corroborated by our observation that reduction of SCs prevented 
appropriate ECM remodeling in response to chronic stretch.
From a clinical standpoint, this is a compelling discovery in light of the notable 
abnormalities seen in the pathologic muscles of patients with common muscle disorders. 
Compared with their typically-developing counterparts, the muscles of children with CP 
have increased collagen content, increased bundle passive stiffness, and qualitatively 
increased levels of ECM, consistent with muscle fibrosis20. As previously discussed, these 
contractured muscles also have considerable atrophy and significantly reduced SC 
number22,23, providing evidence that a major role of SCs is to regulate the extracellular 
muscle environment. It is not clear why children with CP, who also have lower activity 
levels, have these ECM changes, develop contractures, or have reduced SC number. 
However without sufficient SC numbers, it appears as though this process of ECM 
regulation fails and results in the muscle contracture development. In support of this 
conjecture, other pathologic muscle conditions associated with marked fibrotic changes, 
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including Duchenne muscular dystrophy (DMD), are also associated with SC depletion. In 
biopsies from children with DMD there is strong evidence to suggest a decline and 
functionality of the satellite cells/muscle progenitors40, and muscle fibrosis is common in 
children with DMD41,42. Additional studies must be performed, however, to determine 
whether contracture formation can be induced from a SC depleted model and to determine 
whether contracture development itself can result in the increased sarcomere length18,20 
observed in children with CP. Importantly, serial casting for up to 2 weeks at the maximal 
possible range of motion is commonly used for increasing joint excursion and presumably 
muscle fascicle length and serial sarcomere number in children with CP43, who have 
reduced SC numbers. Consequently our results show that the adaptation in response to 
casting-induced stretch, in the presence of a reduced number of SCs might not be 
appropriate. This adds basic science information to the debate as to whether serial casting is 
beneficial for children with CP44. However the maximal ankle angle during serial casting in 
children with CP and our mouse model are different, and given the paucity of direct 
information in muscles of children with CP, this response to stretch may be different in those 
children.
The results of architectural changes in the stretched muscles in this experiment correlate 
closely with findings from other stretch-immobilization experiments in the literature. The 
21% increase in soleus sarcomere number after 2 weeks of stretch is similar to the ~17% 
increase reported in the original study describing the phenomenon of sarcomerogenesis2. 
Furthermore, decreases in muscle mass and PCSA after prolonged immobilization have also 
been reported in other studies, consistent with muscle atrophy25. These findings provide 
validation for the approach used in this experiment.
It should be noted that using previously-described methods in our Pax7-DTA mouse model, 
we were able to obtain a statistically-significant 65% knockdown in SC number. This is a 
smaller reduction than was previously-reported24, raising the possibility that remaining SCs 
compensated for depletion and were sufficient to allow for quantitatively-normal serial 
sarcomerogenesis. However, this incomplete knockdown of SC is similar to the SC number 
observed in muscle of children with CP, where SCs are depleted by 60–70%22,23. Thus, we 
believe that the findings we present are of clinical relevance despite incomplete SC 
depletion.
This study has important limitations. Due to size limitations with the use of the soleus, we 
quantified the SC number using flow cytometry with the quadriceps and gastrocnemius 
muscles. In this previously established transgenic mouse model the SC reduction should be 
systemic45, and consequently the results observed in overall reduction between the vehicle 
control group and the tamoxifen treatment group should hold true for the soleus. Based on 
the significant phenotypic differences seen in experimental and control muscle tissues that 
were visible with light microscopy, it was not feasible to perform sarcomere length analysis 
in a truly blinded fashion. Furthermore, muscle architectural measurements may have been 
skewed by the presence of proximal and distal tendon samples which were included in the 
muscle mass and PCSA determination to allow proper pinning of the muscles at in vivo 
lengths. In addition, to have sufficient muscle tissue to perform both architectural studies 
and histologic sectioning, each studied muscle was divided longitudinally to provide 2 
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specimens for each muscle. This limited our ability to directly quantify total fiber number 
but not fiber size in each muscle. In addition, we only analyzed the muscles at the 14-day 
time point. Consequently our work is not informative of the timeline of development of 
fibrosis and pathological changes since we were unable to test intermediate time points. Due 
to practical consideration we used the contralateral leg as internal control per mouse rather 
than a truly non-manipulated control. However as we elaborate in our methods we used 
appropriate littermate controls as treatment control (i.e. tamoxifen vs. vehicle) and wild-type 
mice (treated with tamoxifen) as our negative control. There might be changes in the 
contralateral leg due to the cast, but this should not impact the serial sarcomere number, i.e. 
sarcomere number associated with the length of the muscle fascicle. In general, our mice are 
very mobile, and gait patterns are fairly normal. We and others have used this model 
extensively to study sarcomere adaptation to length changes25,2,1. Another important point, 
which is an ongoing debate in the field, is the translational capacity of using murine models 
to understand human disease and biology. SCs in mice and humans may differ in their 
phenotype and functionality46, however murine transgenic models allow manipulation of 
conditions in a way that is currently not possible in humans. Finally, it is worth noting that 
SC numbers differ between genders and muscles47, and consequently we used mixed gender 
groups in our 3 groups.
In summary, this study demonstrates that, while SC reduction does not preclude serial 
sarcomere addition in response to chronic stretch, it results in pathological changes in the 
muscle, including reduction of myofiber number, decreased muscle area fraction, and 
increased muscle fibrosis.
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Fig. 1. Successful conditional ablation of satellite cells
(A) Timeline of experimental protocol indicating treatment either by oral gavage of 
tamoxifen or vehicle, followed by washout period, number of days casted, and day when the 
muscle was harvested. (B) Fluorescence-activated cell sorting (FACS) analysis from 
gastrocnemius and quadriceps muscles in treated mice confirmed satellite cell reduction, i.e., 
α7-integrin+/NCAM+/CD31−/CD45− cells in tamoxifen-treated Pax7-DTA muscles relative 
to vehicle-treated Pax7-DTA muscles (compare blue boxes, which display representative cell 
populations). Image is representative of 4 independent tests. (C) Quantification of FACS 
analysis shows an average 65% (range 58–78) reduction of satellite cells in tamoxifen-
treated muscles compared with vehicle-treated muscles (n=4 per group, P<0.01, plotted as 
mean + SEM).
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Fig. 2. Sarcomere number adaptation occurs after satellite-cell reduction
Serial sarcomere number addition in soleus (A) and subtraction in tibialis anterior (B) 
muscles from casted and uncasted hindlimbs of wild-type, tamoxifen-treated mice 
(tamoxifen control group); Pax7-DTA, tamoxifen-treated mice (experimental group); and 
Pax7-DTA, vehicle-treated mice (treatment control group). Data are plotted as mean + SEM 
(N=10 for experimental group, N=7–8 for control groups).* Statistically significant 
difference between casted and uncasted hindlimbs (P<0.05).
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Fig. 3. Satellite cell depleted muscle is fibrotic with decreased muscle fiber sizes
(A) H&E stains of vehicle-treated Pax7-DTA soleus (left) and tamoxifen-treated Pax7-DTA 
soleus (right) on the cast side with a 20X objective (Scale bar = 50 μm). Images are 
representative of results from 5 independent samples per group. (B) Laminin antibody 
labeling of vehicle-treated Pax7-DTA soleus (left) and tamoxifen-treated Pax7-DTA soleus 
(right) on the cast side using a 10X objective (Scale bar = 100 μm, for all images). Displayed 
images are representative of 4–5 independent samples per group. (C) Quantification of 
percentage area of H&E stained sections of the soleus that was muscle tissue. (D) 
Quantification of soleus myofiber area calculated from laminin-labeled samples (n=4–5 per 
group). Data are represented as mean ± SEM. *statistically significant differences compared 
to uncasted sided and vehicle-treatment, P<0.05 (D) and **P<0.01 (C).
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